B-cell Lymphoma 
Welcome,         Profile    Billing    Logout  

11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
B-cell Lymphoma
NCT02449278: The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma

Recruiting
3
120
RoW
Consolidation involved-site radiotherapy (ISRT), Consolidation involved-field radiotherapy (IFRT), cyclophosphamide, doxorubicin, vincristine, prednisone
Wuhan University
Diffuse Large B-cell Lymphoma
10/19
10/25
NCT02449265: Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma

Recruiting
3
160
RoW
Consolidation involved-site radiotherapy (ISRT), Consolidation involved-field radiotherapy (IFRT), cyclophosphamide, doxorubicin, vincristine, prednisone
Wuhan University
Diffuse Large B-cell Lymphoma
10/19
10/25
NCT03016000: Thalidomide Maintenance Treatment in DLBCL

Recruiting
3
226
RoW
Thalidomide, Thalomid, Observation
Nanfang Hospital of Southern Medical University
Lymphoma, Large B-Cell, Diffuse
12/19
12/23
NCT02842931: R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Recruiting
3
300
RoW
R-DA-EPOCH-21, R-DA-EPOCH-21 + auto-SCT, R-mNHL-BFM-90, R-mNHL-BFM-90 + auto-SCT
National Research Center for Hematology, Russia, National Research Center for Hematology
Diffuse Large B-Cell Lymphoma
02/20
02/23
DOBL, NCT02964858: Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.

Recruiting
3
840
RoW
Standard Arm, Experimental Arm
Tata Memorial Hospital
NonHodgkin Lymphoma
11/22
06/23
NCT01595048 / 2010-019224-31: Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia

Active, not recruiting
2/3
640
US, Canada, RoW
Rituximab, MOAB IDEC-C2B8, Prednisone, Etoposide, Lastet, Doxorubicin Hydrochloride, Cytarabine, CHX-3311, U-19920, Vincristine Sulfate, Kyocristine, Oncovin, VCR, Vincasar, Cyclophosphamide, Methotrexate, Methylprednisolone, MePRDL, Leucovorin Calcium, CF, Therapeutic Hydrocortisone, Aeroseb-HC, Cetacort, HC, Laboratory Biomarker Analysis
Children's Oncology Group, National Cancer Institute (NCI)
Childhood B Acute Lymphoblastic Leukemia, Childhood Burkitt Leukemia, Childhood Diffuse Large Cell Lymphoma, Mediastinal (Thymic) Large B-Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma
12/20
12/20
NCT02388581: First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

Recruiting
2
30
RoW
Lansoprazole, Amoxicillin, Clarithromycin, Metronidazole, Anti-H. pylori Therapy
National Health Research Institutes, Taiwan, National Taiwan University Hospital, Mackay Memorial Hospital, China Medical University Hospital, Taichung Veterans General Hospital, Changhua Christian Hospital, National Cheng-Kung University Hospital, Chang Gung Memorial Hospital, Kaohsiung Medical University
Gastric Diffuse Large B-cell Lymphoma
12/17
12/24
PTL, NCT02753062: Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma

Recruiting
2
22
RoW
bendamustine, rituximab, symbenda, mabthera
Asan Medical Center, Cheolwon Suh
Diffuse Large B Cell Lymphoma
08/18
08/23
NCT02955628: RICE-ibrutinib in Relapsed DLBCL

Recruiting
2
34
RoW
Ibrutinib-RICE, Imbruvica
Singapore General Hospital, Janssen, LP
Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma Recurrent
08/23
08/23
NCT00423826: Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

No Longer Available
N/A
US
Busulfan, Busulfex®, Myleran®, Cytarabine, DepoCyt(TM), Liposomal Ara-C, Fludarabine phosphate, Fludara, mycophenolate mofetil, Cellcept, tacrolimus, Advagraf, Prograf, Protopic, allogeneic hematopoietic stem cell transplantation, umbilical cord blood transplantation, total-body irradiation
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis
01/15
01/15
GRAALL-2014/B, NCT02617004: Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults

Recruiting
N/A
500
Europe
Assistance Publique - Hôpitaux de Paris
Philadelphia Chromosome Negative Adult B-cell Acute Lymphoblastic Leukemia
12/20
12/25

Download Options